Loading...
| A03134 | Pages: 262 | Dec 2020 | 6437 Views | | |
| Author(s) : Trupti Wadekar, Snehal Manjrekar , Onkar Sumant | Tables: 157 | Charts: 53 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Hemodialysis And Peritoneal Dialysis Market
Request Now !Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys and is usually required for people suffering from chronic renal failure. This procedure is performed for treating kidney disorders and is classified into 2 types: hemodialysis and peritoneal dialysis. In hemodialysis, blood is pumped out of blood vessels and is purified with the help of dialyzer and then returned back to the body through vascular access. In peritoneal dialysis, the principle of the procedure remains same, however the inner lining of stomach called peritoneum is used as a filter to purify blood.
The global hemodialysis and peritoneal dialysis market size was valued at $15,681.81 million in 2019, and is projected to reach $22,164.86 million by 2027, registering a CAGR of 6.0%. This market growth is attributed to surge in incidences of kidney related diseases and problems associated with kidney transplants, as kidney transplantation involves a major surgery, a donor match, and a lifetime regime of immunosuppressant medications to prevent body refutation against the organ. In addition, rise in prevalence of lifestyle and chronic diseases such as obesity, diabetes, and hypertension are projected to further supplement the global hemodialysis and peritoneal dialysis market growth. However, rise in complications related to dialysis treatment such as infections, hypotension, fluid overload, and access point bleeding are likely to obstruct growth of the market in the coming years. Similarly, reimbursement policy concerns in emerging nations impedes growth of the market. This is attributed to the fact that reimbursement for dialysis varies widely in terms of amount & duration between different countries and does not necessarily cover real treatment costs, further discouraging patients and physicians to consider the policy usage. On the other hand, shift in preference of patients toward home hemodialysis (HHD), owing to its effective and patient-centered approach and surge in market strategies such as acquisitions, partnerships, product development, and innovation by key players are expected to offer profitable opportunities for growth of the market during the forecast period.
Get more information on this report : Request Sample Pages
The global hemodialysis and peritoneal dialysis market is segmented on the basis of type, dialysis site, modality, product, and region. By type, it is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is further divided into short-term catheter, chronic catheter, graft, and fistula. By dialysis site, the market is classified into hospitals, clinics & dialysis centers, and home dialysis. The home dialysis segment is further classified into home hemodialysis and home peritoneal dialysis. By modality, it is categorized into conventional and daily (day time, night time). By product, it is segmented into devices and consumables. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Hemodialysis segment is the major contributor toward the market growth, owing to maturity of the hemodialysis and peritoneal dialysis market and is a preferred form of approach among healthcare professionals and patients suffering from end-stage renal disease (ESRD). There are two types of hemodialysis, namely, conventional and daily (short daily and nocturnal hemodialysis). However, owing to efficient removal of toxic substances and rise in demand for homecare among dialysis patients, peritoneal dialysis is expected to be the fastest growing segment during the forecast period.
Get more information on this report : Request Sample Pages
Most patients prefer to receive dialysis treatments through services provided by clinics & dialysis centers, making them the largest contributor to the global hemodialysis and peritoneal dialysis market. Nonetheless, rise in awareness and surge in demand for home healthcare among dialysis patients is expected to make home dialysis fastest growing segment during the forecast period.
Get more information on this report : Request Sample Pages
On the basis of modality, conventional hemodialysis is more frequently used treatment, however, owing to efficient removal of toxic substances and demand for homecare among dialysis patients, daily dialysis is expected to be the fastest growing segment during the forecast period.
Get more information on this report : Request Sample Pages
On the basis of product, consumables are expected to be the fastest growing segment as these products are used frequently, and are constantly needed to be replaced with new ones. For instance, companies are developing catheters for advanced materials that are resistant to chemicals, such as peroxide, iodine, or alcohol. These progressions help increase longevity of catheters and reduce risk of any malfunction. Moreover, there is a growth in demand for antimicrobial coated catheters, which reduces the rate of bloodstream infections. Similarly, innovative technologies used in manufacturing of dialyzers such as increased surface contact and cut‐off membrane dialyzers for better diffusion positively impact on growth of the consumable segment.
Get more information on this report : Request Sample Pages
Asia-Pacific constituted highest hemodialysis and peritoneal dialysis market share in 2019, followed by North America and LAMEA. Asia-Pacific accounted for about 42.3% share in 2019, owing to increase in awareness about advanced dialysis devices among healthcare professionals & patients, developing healthcare infrastructure, and higher prevalence of ESRD. Overall, it is projected that need for dialysis in developing countries of Asia-Pacific would rise sharply in the coming years, reaching higher levels than American and European countries. This is majorly attributed to larger number of undiagnosed patients with kidney related disorders and rise in market penetration by various pharmaceutical companies to reach the untapped regions for geographical expansion.
Get more information on this report : Request Sample Pages
Key Benefits For Stakeholders
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits to the stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Surge in incidences of kidney diseases
3.5.1.2.Issues associated with kidney transplants
3.5.1.3.Rise in prevalence of lifestyle and chronic diseases
3.5.2.Restraints
3.5.2.1.Complications in dialysis treatment
3.5.2.2.Reimbursement policy concerns in emerging nations
3.5.3.Opportunities
3.5.3.1.Shift in preference of patients for home hemodialysis
3.5.3.2.Surge in market strategies by key players
3.6.Prevalence and Incidence of HD and PD: Important demographics
3.7.Pricing analysis
3.8.Average survival time of vascular access products
3.9.Reimbursement scenario for dialysis (per patient)
3.10.List of major morbidities associated with hemodialysis access procedures
3.11.List of major companies delivering dialysis services
CHAPTER 4:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Hemodialysis (HD)
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market share analysis, by country
4.2.4.Short-term Catheter (Non-cuffed tunneled catheters)
4.2.5.Chronic Catheter (Cuffed tunneled catheters)
4.2.6.Graft (AVG)
4.2.7.Fistula (AVF)
4.3.Peritoneal dialysis (PD)
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market share analysis, by country
CHAPTER 5:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE
5.1.Overview
5.1.1.Market size and forecast
5.2.Hospitals
5.2.1.Key market trends and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country
5.3.Clinics & dialysis centers
5.3.1.Key market trends and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country
5.4.Home dialysis
5.4.1.Key market trends and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market share analysis, by country
5.4.4.Market share analysis, by type
5.4.4.1. Home Hemodialysis
5.4.4.1.1.Market size and forecast, by region
5.4.4.1.2.Market share analysis, by country
5.4.4.2. Home Peritoneal Dialysis
5.4.4.2.1.Market size and forecast, by region
5.4.4.2.2.Market share analysis, by country
CHAPTER 6:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY
6.1.Overview
6.1.1.Market size and forecast
6.2.Conventional dialysis
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.2.3.Market share analysis, by country
6.3.Daily dialysis (Day time/ Night time)
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.3.3.Market share analysis, by country
CHAPTER 7:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT
7.1.Overview
7.1.1.Market size and forecast
7.2.Devices
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast
7.2.3.Market share analysis, by country
7.3.Consumables
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast
7.3.3.Market share analysis, by country
CHAPTER 8:HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends and opportunities
8.2.2.Market size and forecast, by country
8.2.3.Market size and forecast, by type
8.2.4.Market size and forecast, by dialysis site
8.2.5.Market size and forecast, by modality
8.2.6.Market size and forecast, by product
8.2.7.U.S.
8.2.7.1.Market size and forecast, by type
8.2.7.2.Market size and forecast, by dialysis site
8.2.7.3.Market size and forecast, by modality
8.2.7.4.Market size and forecast, by product
8.2.8.Canada
8.2.8.1.Market size and forecast, by type
8.2.8.2.Market size and forecast, by dialysis site
8.2.8.3.Market size and forecast, by modality
8.2.8.4.Market size and forecast, by product
8.2.9.Mexico
8.2.9.1.Market size and forecast, by type
8.2.9.2.Market size and forecast, by dialysis site
8.2.9.3.Market size and forecast, by modality
8.2.9.4.Market size and forecast, by product
8.3.Europe
8.3.1.Key market trends and opportunities
8.3.2.Market size and forecast, by country
8.3.3.Market size and forecast, by type
8.3.4.Market size and forecast, by dialysis site
8.3.5.Market size and forecast, by modality
8.3.6.Market size and forecast, by product
8.3.7.UK
8.3.7.1.Market size and forecast, by type
8.3.7.2.Market size and forecast, by dialysis site
8.3.7.3.Market size and forecast, by modality
8.3.7.4.Market size and forecast, by product
8.3.8.France
8.3.8.1.Market size and forecast, by type
8.3.8.2.Market size and forecast, by dialysis site
8.3.8.3.Market size and forecast, by modality
8.3.8.4.Market size and forecast, by product
8.3.9.Spain
8.3.9.1.Market size and forecast, by type
8.3.9.2.Market size and forecast, by dialysis site
8.3.9.3.Market size and forecast, by modality
8.3.9.4.Market size and forecast, by product
8.3.10.Italy
8.3.10.1.Market size and forecast, by type
8.3.10.2.Market size and forecast, by dialysis site
8.3.10.3.Market size and forecast, by modality
8.3.10.4.Market size and forecast, by product
8.3.11.Germany
8.3.11.1.Market size and forecast, by type
8.3.11.2.Market size and forecast, by dialysis site
8.3.11.3.Market size and forecast, by modality
8.3.11.4.Market size and forecast, by product
8.3.12.Rest of Europe
8.3.12.1.Market size and forecast, by type
8.3.12.2.Market size and forecast, by dialysis site
8.3.12.3.Market size and forecast, by modality
8.3.12.4.Market size and forecast, by product
8.4.Asia-Pacific
8.4.1.Key market trends and opportunities
8.4.2.Market size and forecast, by country
8.4.3.Market size and forecast, by type
8.4.4.Market size and forecast, by dialysis site
8.4.5.Market size and forecast, by modality
8.4.6.Market size and forecast, by product
8.4.7.Japan
8.4.7.1.Market size and forecast, by type
8.4.7.2.Market size and forecast, by dialysis site
8.4.7.3.Market size and forecast, by modality
8.4.7.4.Market size and forecast, by product
8.4.8.China
8.4.8.1.Market size and forecast, by type
8.4.8.2.Market size and forecast, by dialysis site
8.4.8.3.Market size and forecast, by modality
8.4.8.4.Market size and forecast, by product
8.4.9.Australia
8.4.9.1.Market size and forecast, by type
8.4.9.2.Market size and forecast, by dialysis site
8.4.9.3.Market size and forecast, by modality
8.4.9.4.Market size and forecast, by product
8.4.10.India
8.4.10.1.Market size and forecast, by type
8.4.10.2.Market size and forecast, by dialysis site
8.4.10.3.Market size and forecast, by modality
8.4.10.4.Market size and forecast, by product
8.4.11.South Korea
8.4.11.1.Market size and forecast, by type
8.4.11.2.Market size and forecast, by dialysis site
8.4.11.3.Market size and forecast, by modality
8.4.11.4.Market size and forecast, by product
8.4.12.Rest of Asia-Pacific
8.4.12.1.Market size and forecast, by type
8.4.12.2.Market size and forecast, by dialysis site
8.4.12.3.Market size and forecast, by modality
8.4.12.4.Market size and forecast, by product
8.5.LAMEA
8.5.1.Key market trends and opportunities
8.5.2.Market size and forecast, by country
8.5.3.Market size and forecast, by type
8.5.4.Market size and forecast, by dialysis site
8.5.5.Market size and forecast, by modality
8.5.6.Market size and forecast, by product
8.5.7.Brazil
8.5.7.1.Market size and forecast, by type
8.5.7.2.Market size and forecast, by dialysis site
8.5.7.3.Market size and forecast, by modality
8.5.7.4.Market size and forecast, by product
8.5.8.Saudi Arabia
8.5.8.1.Market size and forecast, by type
8.5.8.2.Market size and forecast, by dialysis site
8.5.8.3.Market size and forecast, by modality
8.5.8.4.Market size and forecast, by product
8.5.9.South Africa
8.5.9.1.Market size and forecast, by type
8.5.9.2.Market size and forecast, by dialysis site
8.5.9.3.Market size and forecast, by modality
8.5.9.4.Market size and forecast, by product
8.5.10.Rest of LAMEA
8.5.10.1.Market size and forecast, by type
8.5.10.2.Market size and forecast, by dialysis site
8.5.10.3.Market size and forecast, by modality
8.5.10.4.Market size and forecast, by product
CHAPTER 9:COMPANY PROFILES
9.1.FRESENIUS SE AND CO. KGAA
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments
9.2.ASAHI KASEI CORPORATION
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.3.B. BRAUN MELSUNGEN AG
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.3.6.Key strategic moves and developments
9.4.BAXTER INTERNATIONAL INC.
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments
9.5.BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments
9.6.COOK GROUP
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.7.ANGIODYNAMICS INC.
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.8.MEDTRONIC PLC.
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments
9.9.NIKKISO CO. LTD.
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.10.NIPRO CORPORATION
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
LIST OF TABLES
TABLE 01.SIDE EFFECTS OF DIALYSIS
TABLE 02.PREVALENCE AND INCIDENCE OF HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENT (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 03.PRICING ANALYSIS BY ACCESS TYPE: AVERAGE PRICING RANGE (USD)
TABLE 04.AVERAGE SURVIVAL TIME OF VASCULAR ACCESS PRODUCTS
TABLE 05.ACCESS FISTULA AND GRAFTS
TABLE 06.ACCESS CATHETERS
TABLE 07.LIST OF MAJOR COMPANIES DELIVERING DIALYSIS SERVICES
TABLE 08.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 09.GLOBAL HEMODIALYSIS PATIENTS, BY ACCESS TYPE (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 10.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 11.GLOBAL HEMODIALYSIS PATIENTS WITH SHORT TERM CATHETER ACCESS, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 12.GLOBAL HEMODIALYSIS PATIENTS WITH CHRONIC CATHETER ACCESS, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 13.GLOBAL HEMODIALYSIS PATIENTS WITH GRAFT ACCESS, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 14.GLOBAL HEMODIALYSIS FISTULA MARKET, BY REGION (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 15.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SEGMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 16.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 17.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 18.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CLINICS AND DIALYSIS CENTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 19.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME DIALYSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 20.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 21.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 22.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 23.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 24.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 25.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONSUMABLES, BY REGION, 2019–2027 ($MILLION)
TABLE 26.HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 27.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 28.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 29.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 30.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 31.NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 32.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 33.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 34.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 35.U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 36.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 37.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 38.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 39.CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 40.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 41.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 42.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 43.MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 44.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 45.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 46.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 47.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 48.EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 49.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 50.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 51.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 52.UK HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 53.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 54.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 55.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 56.FRANCE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 57.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 58.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 59.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 60.SPAIN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 61.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 62.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 63.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 64.ITALY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 65.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 66.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 67.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 68.GERMANY HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 69.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 70.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 71.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 72.REST OF EUROPE HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 73.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 74.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 75.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 76.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 77.ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 78.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 79.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 80.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 81.JAPAN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 82.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 83.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 84.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 85.CHINA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 86.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 87.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 88.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 89.AUSTRALIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 90.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 91.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 92.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 93.INDIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 94.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 95.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 96.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 97.SOUTH KOREA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 98.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 99.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 100.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 101.REST OF ASIA-PACIFIC HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 102.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 103.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 104.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 105.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 106.LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 107.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 108.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 109.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 110.BRAZIL HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 111.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 112.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 113.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 114.SAUDI ARABIA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 115.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 116.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 117.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 118.SOUTH AFRICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 119.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 120.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DIALYSIS SITE, 2019–2027 ($MILLION)
TABLE 121.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY MODALITY, 2019–2027 ($MILLION)
TABLE 122.REST OF LAMEA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 123.FRESENIUS: COMPANY SNAPSHOT
TABLE 124.FRESENIUS: OPERATING SEGMENTS
TABLE 125.FRESENIUS: PRODUCT PORTFOLIO
TABLE 126.FRESENIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127.ASAHI KASEI: COMPANY SNAPSHOT
TABLE 128.ASAHI KASEI: OPERATING SEGMENTS
TABLE 129.ASAHI KASEI: PRODUCT PORTFOLIO
TABLE 130.B. BRAUN: COMPANY SNAPSHOT
TABLE 131.B. BRAUN: OPERATING SEGMENTS
TABLE 132.B. BRAUN: PRODUCT PORTFOLIO
TABLE 133.B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 134.BAXTER: COMPANY SNAPSHOT
TABLE 135.BAXTER: OPERATING SEGMENTS
TABLE 136.BAXTER: PRODUCT PORTFOLIO
TABLE 137.BAXTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 138.BD: COMPANY SNAPSHOT
TABLE 139.BD: OPERATING SEGMENTS
TABLE 140.BD: PRODUCT PORTFOLIO
TABLE 141.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 142.COOK: COMPANY SNAPSHOT
TABLE 143.COOK: OPERATING SEGMENTS
TABLE 144.COOK: PRODUCT PORTFOLIO
TABLE 145.ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 146.ANGIODYNAMICS: PRODUCT SEGMENTS
TABLE 147.ANGIODYNAMICS: PRODUCT PORTFOLIO
TABLE 148.MEDTRONIC: COMPANY SNAPSHOT
TABLE 149.MEDTRONIC: OPERATING SEGMENTS
TABLE 150.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 151.MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 152.NIKKISO: COMPANY SNAPSHOT
TABLE 153.NIKKISO: OPERATING SEGMENTS
TABLE 154.NIKKISO: PRODUCT PORTFOLIO
TABLE 155.NIPRO: COMPANY SNAPSHOT
TABLE 156.NIPRO: OPERATING SEGMENTS
TABLE 157.NIPRO: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.SEGMENTATION OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
FIGURE 02.TOP INVESTMENT POCKETS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2016–2019*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016–2019* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2016–2019*
FIGURE 06.HIGH BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.MODERATE THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.HIGH COMPETITIVE RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2019
FIGURE 12.RESTRAINTS AND DRIVERS: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
FIGURE 13.PROJECTED PREVALENCE OF CKD IN 2020 AND 2030 IN ADULTS AGED 30 YEARS OR OLDER (U.S.)
FIGURE 14.PREVALENCE OF DIABETES IN POPULATION (MILLIONS) AND DIABETES PREVALENCE (%)
FIGURE 15.DIALYSIS REIMBURSEMENT SCENARIO AROUND THE WORLD
FIGURE 16.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY COUNTRY, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SEGMENT, BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CLINICS AND DIALYSIS CENTERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME DIALYSIS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR DEVICES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 24.COMPARATIVE ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR CONSUMABLES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 25.GLOBAL PREVALENCE OF DIALYSIS, RATE PER MILLION POPULATION (PMP), AGE ≥ 18 YEARS
FIGURE 26.TRENDS IN ANNUAL NUMBER OF ESRD INCIDENT CASES AND STANDARD INCIDENCES RATES PER MILLION EACH YEAR, U.S.
FIGURE 27.FRESENIUS: NET SALES, 2017–2019 ($MILLION)
FIGURE 28.FRESENIUS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 29.FRESENIUS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 30.ASAHI KASEI: NET SALES, 2017–2019 ($MILLION)
FIGURE 31.ASAHI KASEI: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 32.ASAHI KASEI: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 33.B. BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 34.B. BRAUN: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 35.B. BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 36.BAXTER: NET SALES, 2017–2019 ($MILLION)
FIGURE 37.BAXTER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 38.BAXTER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 39.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 40.BD: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 41.BD: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 42.ANGIODYNAMICS: NET SALES, 2017–2019 ($MILLION)
FIGURE 43.ANGIODYNAMICS: REVENUE SHARE, BY SEGMENTS, 2019 (%)
FIGURE 44.ANGIODYNAMICS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 45.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 47.MEDTRONIC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 48.NIKKISO: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.NIKKISO: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 50.NIKKISO: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.NIPRO: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.NIPRO: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 53.NIPRO: REVENUE SHARE, BY REGION, 2019 (%)
Hemodialysis and peritoneal dialysis is the most popular and preferred form of treatment for chronic renal diseases and kidney failures as compared to kidney transplantation. On the contrary, factors, such as non-eligibility of patients suffering from heart or liver disease for kidney transplantation, rise in incidences of kidney failures, growth in number of ESRD patients, increase in occurrences of diabetes, surge in funding for development of new products with advanced technology, and lack of matching donors for kidney transplantation are expected to propel growth of the hemodialysis and peritoneal dialysis market during the forecast period. However, lack of awareness about kidney diseases, complications associated with hemodialysis and peritoneal dialysis treatments, and reduction in reimbursements for dialysis across developing nations are expected to obstruct the market growth. The peritoneal dialysis segment is predicted to grow at the highest rate and offer beneficial opportunities for market players. Peritoneal dialysis is preferred over hemodialysis, owing to advantages it offers, such as low number of clinical visits, negligible usage of needles, and easy-to-use machinery, which boosts the segment growth.
The use of hemodialysis and peritoneal dialysis is highest in Asia-Pacific, owing to increase in adoption of these products, high prevalence rate of diabetes and hypertension, and rise in awareness regarding various kidney diseases among population. Although use of hemodialysis and peritoneal dialysis in Europe and LAMEA is low, the adoption rate is expected to increase, owing to rise in disposable income, increase in the incidence rate of kidney failures, and presence of large geriatric population.
A. The key trends in the Hemodialysis and Peritoneal Dialysis Market are rise in incidences of kidney diseases globally and increase in occurrences of lifestyle and chronic diseases.
A. The top companies that hold the market share in Hemodialysis and Peritoneal Dialysis Market are Fresenius, Nipro Corporation, B. Braun, Nikkiso, and Baxter International Inc.
A. No, there is no value chain analysis provided in the Hemodialysis and Peritoneal Dialysis Market report
A. The total market value of Hemodialysis and Peritoneal Dialysis Market is $22,164.86 million
A. The forecast period in the report is from 2020 to 2027
A. The market value of Hemodialysis and Peritoneal Dialysis Market in 2019 was $15,681.8 Million
A. The base year for the report is 2019
A. Yes, Hemodialysis and Peritoneal Dialysis companies are profiled in the report
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
